Acelyrin June 30, 2024 A late-stage clinical biopharma company focused on providing life-changing new treatment options for patients.
Kyverna June 30, 2024 A patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases.